| Item Type | Name |
|
Concept
|
Drug Therapy
|
|
Concept
|
Drug Therapy, Combination
|
|
Academic Article
|
Contemporary management of refractory hypertension.
|
|
Academic Article
|
Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates.
|
|
Academic Article
|
Efficacy of low-dose spironolactone in subjects with resistant hypertension.
|
|
Academic Article
|
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
|
|
Academic Article
|
Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
|
|
Academic Article
|
The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.
|
|
Academic Article
|
Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial.
|
|
Academic Article
|
Resistant hypertension and aldosteronism.
|
|
Academic Article
|
Resistant hypertension and hyperaldosteronism.
|
|
Academic Article
|
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
|
|
Academic Article
|
Current options for the treatment of resistant hypertension.
|
|
Academic Article
|
Treatment of resistant hypertension.
|
|
Academic Article
|
Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension.
|
|
Academic Article
|
Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.
|
|
Academic Article
|
24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.
|
|
Academic Article
|
Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension.
|
|
Academic Article
|
Refractory hypertension: definition, prevalence, and patient characteristics.
|
|
Academic Article
|
Resistant hypertension: bad and getting worse.
|
|
Academic Article
|
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.
|
|
Academic Article
|
Resistant hypertension and aldosterone: an update.
|
|
Academic Article
|
Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
|
|
Academic Article
|
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure.
|
|
Academic Article
|
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.
|
|
Academic Article
|
11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.
|
|
Academic Article
|
Resistant Hypertension: An Update.
|
|
Academic Article
|
Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
|
|
Academic Article
|
Association Between Sleep Apnea and Blood Pressure Control Among Blacks.
|
|
Academic Article
|
The ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence.
|
|
Academic Article
|
Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines.
|
|
Academic Article
|
Treatment of Resistant and Refractory Hypertension.
|
|
Academic Article
|
Reserpine Substantially Lowers Blood Pressure in Patients With Refractory Hypertension: A Proof-of-Concept Study.
|